Skip to main content

Fidelity, Arch back precision medicine startup's $178M round

Precision medicine startup FogPharma has raised $178 million as it prepares to launch its first human trial within the next year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.